CN104435444A - Medicament for treating prostatic hyperplasia - Google Patents
Medicament for treating prostatic hyperplasia Download PDFInfo
- Publication number
- CN104435444A CN104435444A CN201410640092.XA CN201410640092A CN104435444A CN 104435444 A CN104435444 A CN 104435444A CN 201410640092 A CN201410640092 A CN 201410640092A CN 104435444 A CN104435444 A CN 104435444A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- talcum
- medicament
- rehmanniae preparata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract 2
- 239000000454 talc Substances 0.000 claims abstract description 20
- 229910052623 talc Inorganic materials 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims description 20
- 235000012222 talc Nutrition 0.000 claims description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 206010020718 hyperplasia Diseases 0.000 claims description 15
- 210000002307 prostate Anatomy 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229940095686 granule product Drugs 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 240000003146 Lobelia chinensis Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000271039 Agkistrodon Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating prostatic hyperplasia. The medicament is characterized in that based on weight, the medicament comprises 10-12 parts of pilose asiabell root, 10-12 parts of milkvetch root, 10-12 parts of Chinese lobelia herb, 10-12 parts of heartleaf houttuynia herb, 10-12 parts of safflower, 10-12 parts of radix rehmanniae preparata, 10-12 parts of common macrocarpium fruits, 10-12 parts of talc, 10-12 parts of twotooth achyranthes root, 10-12 parts of oriental waterplantain rhizome, 10-12 parts of tree peony bark, 10-12 parts of plantain seeds and 10-12 parts of talc. The medicament has the advantages of easiness in obtainment of the raw materials, low cost, significant treatment effect and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal formulae.
Background technology
Chinese medicine (Chinese herbology, Traditional Materia Medica), refers to the medicine of application under Han nationality's folk medicine instructs.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.Minority Chinese medicine comes from foreign country, as Radix Panacis Quinquefolii.China working people, for thousands of years in the process combated the disease, by practice, is constantly familiar with, have accumulated abundant medicinal knowledge gradually.Because word in period in romote antiquity is not emerging, these knowledge can only rely on transmission from master to disciple oral instruction, have had word afterwards, and have just recorded gradually, and occurred medical book.These books serve sums up forefathers' experience and is convenient to the effect spreading and promote.Chinese medicine has the history of thousands of years, and be that the very rich experience that Chinese people struggle with disease is for a long time summed up, the prosperity for the Chinese nation has huge contribution.Because medicine medium-height grass class is in the great majority, so the books recording medicine are just called " book on Chinese herbal medicine ".According to textual criticism, when Qin Han, book on Chinese herbal medicine is popular more, but these books on Chinese herbal medicine are lost all unfortunately, can not investigate.The herbal the earliest works now known is called Shennong's Herbal, pandect is totally three volumes, record medicine comprise dynamic, plant, ore deposit three class, totally 365 kinds, every medicine item is downloaded to be had nature and flavor, function and cures mainly, and another example in order describes the basic theories of medication briefly, as toxicity or no toxicity, four natures and five flavors of drug, compatibility law, method of administration and ball, fall apart, the dosage form such as cream, wine, can say it is the summary of China's knowledge of medication before the Chinese, and lay a good foundation for later pharmaceutical development.Greatest works in China's book on Chinese herbal medicine history, achievement extremely brilliant in the history of science of Ye Shi China.Now affecting larger is " Dictionary of Chinese Pharmacy " that nineteen thirty-five Chen Cunren writes.Pandect 2,700,000 word, receive 4300, medicine order, every medicine is introduced name, ancient books another name, basic, the place of production, form, character, composition, usefulness respectively, cured mainly, successive dynasties description textual criticism, discrimination, person of modern times's theory, fit applications, consumption, use compatibility and incompatibility of drugs, reference material etc. 21.Abundant information, comprehensively, summarize relevant discussion at all times, and drawings attached.It is first large-scale dictionary on Traditional Chinese Medicine Phylogeny.Maybe about 7,000 hundred million will be reached to Chinese herbal medicine industry total industrial output value in 2015.
Through general retrieval, do not find the scheme identical with present patent application.
Summary of the invention
The object of the invention is to: propose one and treat prostate hyperplasia disease drug.
Treatment prostate hyperplasia disease drug of the present invention, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition.
Treatment prostate hyperplasia disease drug of the present invention, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, filter and remove residue, point 3 decoction being taken warmly, every day 1 dose.
Treatment prostate hyperplasia disease drug of the present invention, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
Treatment prostate hyperplasia disease drug of the present invention, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Treatment prostate hyperplasia disease drug of the present invention, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, filter and remove residue, point 3 decoction being taken warmly, every day 1 dose.
Chinese medicinal formulae of the present invention is proved recipe handed down from one's ancestors, in the past few decades, has treated many patients, has now enumerated model case as follows:
Model case clinical effectiveness:
Patient land, 53 years old, frequent lower abdomen was uncomfortable, frequent micturition, urgent micturition, dysurea; Examination in hospital is prostate hyperplasia; Take treatment prostate hyperplasia disease drug of the present invention, 3 days, symptom slowed down, and urine is discharged smoothly; Use 15 days again, transference cure, recovery from illness.
Patient Lee, 33 years old, dysurea; Examination in hospital is prostate hyperplasia; Take treatment prostate hyperplasia disease drug of the present invention, 2 days, symptom slowed down; Use 7 days again, transference cure, recovery from illness.
Claims (4)
1. a treatment prostate hyperplasia disease drug, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition.
2. a treatment prostate hyperplasia disease drug, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Pulverize, packaging, obtains product.
3. a treatment prostate hyperplasia disease drug, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
4. a treatment prostate hyperplasia disease drug, it is characterized in that: by weight, by Radix Codonopsis 10-12 parts, the Radix Astragali 10-12 parts, Herba Lobeliae Chinensis 10-12 parts, Herba Houttuyniae 10-12 parts, 10-12 parts, Flos Carthami, 10-12 parts, Radix Rehmanniae Preparata, Fructus Corni 10-12 parts, 10-12 parts, Talcum, Radix Achyranthis Bidentatae 10-12 parts, Rhizoma Alismatis 10-12 parts, Cortex Moutan 10-12 parts, Semen Plantaginis 10-12 parts, 10-12 parts, Talcum composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410640092.XA CN104435444A (en) | 2014-11-13 | 2014-11-13 | Medicament for treating prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410640092.XA CN104435444A (en) | 2014-11-13 | 2014-11-13 | Medicament for treating prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104435444A true CN104435444A (en) | 2015-03-25 |
Family
ID=52882705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410640092.XA Pending CN104435444A (en) | 2014-11-13 | 2014-11-13 | Medicament for treating prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104435444A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1739713A (en) * | 2005-09-16 | 2006-03-01 | 修涞贵 | Prostatosis treating Chinese medicine prepn and its prepn process |
| CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
| CN103800621A (en) * | 2014-02-27 | 2014-05-21 | 徐晟伟 | Traditional Chinese medicine composition for treating prostatic hyperplasia and prostatitis |
| CN104043010A (en) * | 2014-06-25 | 2014-09-17 | 姜丽莎 | Traditional Chinese medicine (TCM) composition for treating prostatitis |
-
2014
- 2014-11-13 CN CN201410640092.XA patent/CN104435444A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1739713A (en) * | 2005-09-16 | 2006-03-01 | 修涞贵 | Prostatosis treating Chinese medicine prepn and its prepn process |
| CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
| CN103800621A (en) * | 2014-02-27 | 2014-05-21 | 徐晟伟 | Traditional Chinese medicine composition for treating prostatic hyperplasia and prostatitis |
| CN104043010A (en) * | 2014-06-25 | 2014-09-17 | 姜丽莎 | Traditional Chinese medicine (TCM) composition for treating prostatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN101670071A (en) | Traditional Chinese medicine preparation for treating cancer and preparation method thereof | |
| CN104435424A (en) | Medicine for treating male climacteric syndrome | |
| CN103845417A (en) | Chinese herbal granule used for relieving pain caused by sudden sprain in lumbar region | |
| CN104435252A (en) | Medicine for treating acute mastitis | |
| CN104383486A (en) | Medicament for treating bronchitis of children | |
| CN104367888A (en) | Medicine for treating acute and chronic balanitis | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
| CN104383485A (en) | Medicine for treating infantile anorexia | |
| CN104367951A (en) | Medicine for treating prostate hyperplasia | |
| CN104367949A (en) | Medicament for treating urinary calculus | |
| CN104383046A (en) | Medicament for treating infantile diarrhea | |
| CN1240415C (en) | Tablets against allergic purpura | |
| CN101912537A (en) | Chinese medicinal preparation for treating cerebrovascular neuropathic pain | |
| CN104435444A (en) | Medicament for treating prostatic hyperplasia | |
| CN104367777A (en) | Medicine for treating spermatorrhea | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN104383223A (en) | Medicine for treating chicken pox in children | |
| CN104056017A (en) | Traditional Chinese medicine composition for treating rheumatism and preparation method thereof | |
| CN104435313A (en) | Medicine for treating haemorrhoids | |
| CN104367730A (en) | Medicine for treating postpartum urinary retention | |
| CN104436113A (en) | Medicine for treating vomitus gravidarum | |
| CN104435350A (en) | Drug for treating functional uterine bleeding | |
| CN104547441A (en) | Medicine for treating tetanus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |